Keywords
bacteriophage, Citrobacter spp., T4-like bacteriophage, Claries gariepinus, aquaculture, phage therapy
This article is included in the Genomics and Genetics gateway.
The emergence of antibiotic resistance among bacterial pathogens poses a significant threat to aquaculture and public health. This study presents the characterization of a novel bacteriophage, designated as Ursula, specifically targeting Citrobacter, a prominent pathogen affecting fish populations. We isolated Ursula from aquatic environments during a search for novel phages active against fish pathogens, and conducted a comprehensive analysis of its morphological, genomic, and lytic properties. Transmission electron microscopy revealed that Ursula has a myovirus morphology, being a rather large T4-like phage. Genomic sequencing identified a double-stranded linear DNA genome of approximately 183 kb, containing unique genes associated with lytic activity and host recognition. This phage is related to other T4-like Citrobacter phages, being a new species.
bacteriophage, Citrobacter spp., T4-like bacteriophage, Claries gariepinus, aquaculture, phage therapy
Aquaculture gained popularity as a main production way of fish in many countries.1 Citrobacter bacteria, particularly Citrobacter freundii, have emerged as significant pathogens in aquaculture, leading to a range of diseases that affect various fish species.2–4 These opportunistic pathogens can cause infections characterized by symptoms such as hemorrhaging, ulcers, and systemic disease, which ultimately compromise fish health and survival. The presence of Citrobacter in aquaculture systems is often exacerbated by environmental stressors, poor water quality, and overcrowding, creating conditions conducive to outbreaks.5 As these bacteria proliferate, they can lead to high mortality rates among infected fish, resulting in substantial economic losses for aquaculture operations. The costs associated with treatment, increased feed conversion ratios due to stress, and the loss of marketable fish can severely impact the profitability of fish farms. Furthermore, the rise of antibiotic resistance among Citrobacter strains complicates treatment options, necessitating a shift towards alternative management strategies. Consequently, addressing Citrobacter-induced diseases is crucial not only for maintaining fish health but also for ensuring the sustainability and economic viability of the aquaculture industry.
New bacteriophages as economically viable tools for Citrobacter biocontrol are highly demanded by industry. Here, we present an isolation and genome analysis of a novel bacteriophage infecting ichtyopathogenic Citrobacter strains, potentially attractive for phage prophylaxis and therapy in aquaculture.
The bacteriophage Ursula was isolated during efforts to sample diverse bacteriophages from aquatic environments, specifically targeting Citrobacter spp. strains known to cause infections in African sharptooth catfish (Clarias gariepinus) in Russian aquaculture facilities. On September 14, 2021, a water sample was collected from the Norishka Stream in Mikhailovsky Park, Moscow, Russia. To isolate the phage, the following enrichment process was used:
Initial Preparation: 0.5 liters of unsterilized water were added to a 2-liter sterile plastic bottle.
Medium Addition: 50 milliliters of sterile 10× LB medium were mixed into the water (the 1× medium contains: 10 g Bacto Tryptone (Amresco, Am-J859-0.25), 5 g yeast extract (Amresco, J850-500G), 10 g NaCl (Amresco, J869-500G), and distilled water up to 1 liter).
Bacterial Culture Introduction: 0.5 milliliters of an overnight liquid culture of Citrobacter spp. CF69 strain were added to the enriched mixture.
Incubation: The enriched culture was incubated at 37°C with shaking at 240 rpm.
After incubation, 1 milliliter of the enriched culture was centrifuged at 12,000 rpm using a tabletop microcentrifuge. The resulting supernatant was filtered through a 0.22-micron syringe membrane filter (Millex-GP, Millipore) and then plated onto a lawn of Citrobacter spp. CF69 strain using the standard double-layer method.6
Phage plaques were formed after an overnight incubation at 37 °C. The phage was purified using two consecutive single-plaque isolations. To obtain a high-titer lysate, five 90 mm Petri dishes were filled with solid LB medium (15 g of Bacto Agar (BD214030, BD Difco) per 1 l). Without drying the plates, they were overlaid with 5 ml of soft LB agar (6 g Bacto Agar (BD214030, BD Difco) per 1 l) per plate. Soft agar was inoculated with 300 μl of a 4h log-phase liquid culture of the host strain and approximately 1×105 PFU of the phage per plate. The plates were incubated overnight at 37 °C. To extract the phage, the soft agar layer was gently destroyed with a spreader, transferred into 50 ml plastic centrifuge tubes, and layered with 10 ml of LB medium. Chloroform (Fisher Scientific, C298-4) (100 μL) was added to each tube, followed by vigorous vortexing for 1 min, and allowed to stand at room temperature for 2 h. After incubation, the agar fragments and bacterial cells were pelleted by centrifugation at 10 000 g for 5 min, and the supernatant was collected and centrifuged again under the same conditions. The phage clarified stock was pelleted in Beckman Ti45 angle rotor (75 000 g, 1 h, 20 °C), resuspended in saline and layered on sucrose step gradient in 5 ml tubes (60%-50%-40%-30%-20% sucrose w/w, 800 μL each). Tubes were centrifuged in Beckman SW55Ti swing bucket rotor (75 000 g, 1 h, 20 °C) and a compact opalescent band between 40% and 50% layers was removed, corresponding to intact phage particles.7 The purified phage sample was used for DNA extraction and transmission electron microscopy (TEM), as previously described.8 Briefly, a drop of purified phage preparation was adsorbed on a carbon-coated TEM support grids, negatively contrasted with 1% uranyl acetate in methanol (Reachim, USSR), dried and studied in Jeol JEM-1400Flash electron microscope Jeol Ltd., Japan).
To extract phage DNA, the high-titer phage stock (about 1011 pfu/ml) was incubated with DNase (Thermo Scientific, EN0521) at a concentration of 0.01 mg/ml for 30 minutes at room temperature to destroy extraneous DNA traces. Subsequently, the phage particles were collected via ultracentrifugation in an angle rotor at room temperature (Beckman 45Ti, 1 hour, 75,000 g). Genomic DNA was extracted from pelleted bacteriophage using CTAB (cetyltrimethylammonium bromide) extraction as previously described.9 The quality and quantity of the DNA were assessed using agarose gel electrophoresis and a Qubit dsDNA HS fluorometric assay (Qubit, USA). Libraries of phage genomic DNA were prepared and sequenced using an Ion Proton sequencer (Applied Biosystems, Foster City, CA, USA) with standard reagents according to the manufacturer’s protocol. Raw sequencing reads were pooled and filtered using the error-correction tool Pollux (RRID:SCR_026200). Final contigs were assembled using Newbler version 3.0 (RRID:SCR_011916) (Roche Diagnostics, USA), yielding a single contig representing the phage genome, consisting of 183,411 base pairs with an average coverage of 200 bp.
Annotation was performed using Prokka10 (RRID:SCR_014732) and Pharokka11 (RRID:SCR_026017)-Phold (RRID:SCR_026016)-Phynteny (RRID:SCR_026015) pipeline with subsequent manual curation. Potential open reading frames (ORFs) were initially detected using GeneMarkS (https://genemark.bme.gatech.edu/genemarks.cgi) (RRID:SCR_011930) and subsequently analyzed using HMMER12 (RRID:SCR_005305), HHPRED13 (RRID:SCR_010276) (MPI Bioinformatics Toolkit), NCBI BLAST14 (RRID:SCR_004870), and tRNAscan-SE15 (RRID:SCR_008637).
The bacteriophage Ursula was found to be a relatively large myovirus with an elongated head, suggesting it belongs to T4 phage group ( Figure 1). The genome consisted of 183 411 b.p. and encoded 343 ORF.
Numerous proteins constituting a contractile phage tail were identified, consistent with the TEM examination results. The Ursula genome also contains genes for an efficient host defense overtake and metabolism switching, including highly cytotoxic Ndd-like nucleoid disruption protein (Ursula_0014), DenB-like DNA endonuclease IV capable of destroying host DNA replication on dC residues. (Ursula_ 0017), small protein inhibitor of MrcBC restriction participating in host takeover (Ursula_0004), duplicated cef modifier of suppressor tRNAs (Ursula_0033, Ursula_0044), a number of genes involved in DNA replication and modification (glucosyltransferases, thymidylate synthase, anaerobic NrdD-like ribonucleotide reductase, NUDIX hydrolase, 2-oxoglutarate-dependent oxygenase, rNDP reductase, DHFR etc.) as well as cytotoxic proteins and recombination mediators. Twelve tRNA genes were detected. Phage Ursula lacks any genomic indicators that could be linked to a lysogenic lifestyle or virulence factors of this phage. A BLASTN search against the NCBI Nucleotide collection produced a number of relevant hits with a good homology, suggesting placement of this phage to Merlin (NCBI NC_028857.1) and Moon (NCBI NC_027331.1), cluster of T4-like Citrobacter spp. bacteriophages, although their genomes are about 6-7% shorter, with gaps diffused along the entire genome. Therefore, we conclude that phage Ursula represents a novel species in T4-like group of Citrobacter spp. bacteriophages, and numerous enzymes and regulatory proteins encoded in its genome make it a good candidate for phage therapy applications.
NCBI GenBank: Genomic DNA sequence of Ursula bacteriophage. Accession number PQ589834; https://www.ncbi.nlm.nih.gov/nuccore/PQ589834 (nucleotide: PQ589834).
Figshare: Morphology of the Ursula phage virion, Doi: https://doi.org/10.6084/m9.figshare.28092209.v1.16
This project contains the following underlying data:
Figshare: Ursula bacteriophage genome sequence in GenBank format, Doi: https://doi.org/10.6084/m9.figshare.28092218.v1.17
This project contains the following underlying data:
Data are available under the terms of the Creative Commons Attribution 4.0 International license (CC-BY 4.0).
All software used in this work is freely available online using respective RRIDs supplied in text.
Views | Downloads | |
---|---|---|
F1000Research | - | - |
PubMed Central
Data from PMC are received and updated monthly.
|
- | - |
Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list:
Sign up for content alerts and receive a weekly or monthly email with all newly published articles
Already registered? Sign in
The email address should be the one you originally registered with F1000.
You registered with F1000 via Google, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Google account password, please click here.
You registered with F1000 via Facebook, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Facebook account password, please click here.
If your email address is registered with us, we will email you instructions to reset your password.
If you think you should have received this email but it has not arrived, please check your spam filters and/or contact for further assistance.
Comments on this article Comments (0)